Cargando…
Design, Synthesis, and Evaluation of Nonretinoid Retinol Binding Protein 4 Antagonists for the Potential Treatment of Atrophic Age-Related Macular Degeneration and Stargardt Disease
[Image: see text] Accumulation of lipofuscin in the retina is associated with pathogenesis of atrophic age-related macular degeneration and Stargardt disease. Lipofuscin bisretinoids (exemplified by N-retinylidene-N-retinylethanolamine) seem to mediate lipofuscin toxicity. Synthesis of lipofuscin bi...
Autores principales: | Cioffi, Christopher L., Dobri, Nicoleta, Freeman, Emily E., Conlon, Michael P., Chen, Ping, Stafford, Douglas G., Schwarz, Daniel M. C., Golden, Kathy C., Zhu, Lei, Kitchen, Douglas B., Barnes, Keith D., Racz, Boglarka, Qin, Qiong, Michelotti, Enrique, Cywin, Charles L., Martin, William H., Pearson, Paul G., Johnson, Graham, Petrukhin, Konstantin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174998/ https://www.ncbi.nlm.nih.gov/pubmed/25210858 http://dx.doi.org/10.1021/jm5010013 |
Ejemplares similares
-
Molecular basis for the interaction of cellular retinol binding protein 2 (CRBP2) with nonretinoid ligands
por: Silvaroli, Josie A., et al.
Publicado: (2021) -
Comparative pharmacokinetics and pharmacodynamics of the advanced Retinol-Binding Protein 4 antagonist in dog and cynomolgus monkey
por: Racz, Boglarka, et al.
Publicado: (2020) -
Nonretinoid chaperones improve rhodopsin homeostasis in a mouse model of retinitis pigmentosa
por: Vats, Abhishek, et al.
Publicado: (2022) -
The STArgardt Remofuscin Treatment Trial (STARTT): design and baseline characteristics of enrolled Stargardt patients
por: Dhooge, Patty P.A., et al.
Publicado: (2022) -
Familial discordance in Stargardt disease
por: Burke, Tomas R., et al.
Publicado: (2012)